Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of GSK2292767 in Healthy Participants Who Smoke Cigarettes [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetics study of GSK2292767 in healthy participants who smoke cigarettes; results completed with posted results in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GSK2292767

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED | Results posted: 2019-05-28